Covid-19

top of page

May 17
3 min

New viruses on the horizon

Oct 20, 2023
3 min

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses

Apr 21, 2023
1 min

Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19

Mar 25, 2022
3 min

CELONIC to become a long-term partner of the Federal Republic of Germany for vaccine supply

Jan 13, 2022
3 min

Apogenix Receives €20.7 Million in Public Funding

Dec 12, 2021
3 min

Visualising Cell Structures in Three Dimensions in Mere Minutes

Oct 19, 2021
4 min

Genomic tracking of the COVID-19 pandemic in England

Sep 10, 2021
1 min

Funding for Covid-19 drug development announced to two BioRN members

Sep 1, 2021
3 min

Innovative Drug Discovery

Aug 29, 2021
2 min

Superspreading events as drivers of SARS-CoV-2 evolution

Aug 24, 2021
2 min

MASSIF-1 beamline in Grenoble supports COVID-19 drug discovery

Jun 17, 2021
1 min

AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine

Apr 26, 2021
2 min

First hospitalized COVID-19 patient treated with the antibody drug candidate COR-101

Apr 23, 2021
3 min

Different immune responses identified in patients with COVID-19

Apr 14, 2021
2 min

Putting computing power together against SARS-CoV-2

Mar 30, 2021
2 min

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses

Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year More...

Mar 16, 2021
3 min

CORAT Therapeutics GmbH obtained regulatory authorization for clinical phase Ib/II trial

Feb 22, 2021
1 min

Multiplex antibody tests

Dec 18, 2020
2 min

Human antibody against COVID-19 ready for clinical trials

Dec 7, 2020
3 min

How human antibody COR-101 neutralizes the coronavirus SARS-CoV-2

bottom of page